Actelion is a Swiss biopharmaceutical company founded in 1997. Located in South San Francisco, our US offices are situated in the hub of California's pharmaceutical and biotech development region. Today with about 2,500 people in 30 countries we focus on discovery, development and marketing of innovative drugs for highly unmet medical needs Actelion combines the innovation, entrepreneurial spirit and flexibility of biotech with the financial, risk management, regulatory and commercial discipline of a large pharmaceutical company. We have ambitious plans to keep improving and growing – and are looking for people as innovative as ourselves.
For all Actelion Clinical Research US opportunities in Cherry Hill, NJ and other clinical development field positions in the US
For global job vacancies
Actelion is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristics protected by law.
As a federal contractor, Actelion has established affirmative action programs to ensure non-discrimination and affirmative action in Actelion’s policies and practices for qualified women, minorities, protected veterans, and individuals with disabilities. The narrative portions of Actelion’s affirmative action plans for individuals with disabilities and veterans are available for inspection at our offices during normal business hours. Employees and applicants interested in inspecting these plans should contact our Human Resources department at email@example.com for assistance.
If you need special assistance or accomodation to apply for a posted position, contact Human Resources department at firstname.lastname@example.org or by calling 650-624-6900.
Please note: Actelion does not solicit applicants through text or instant messages. Actelion does not ask applicants to send money or private information. If you have received a fraudulent message please file a complaint at http://www.ic3.gov/ so that the FBI can gather all of the relevant information.